PerkinElmer Expands Horizons with $383 Million CRISPR Tech AcquisitionAcquisitions, Business, Cell engineering, CRISPR, Gene Editing, Gene modulation, Life Sciences, RNA Interference (RNAi)Intent on growing PerkinElmer’s life sciences portfolio, the company agreed to acquire cell engineering specialist Horizon Discovery Group for $383 million. Read more November 3, 2020/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/11/PerkinElmer-Expands-Horizons-with-383-Million-CRISPR-Tech-Acquisition-BioSpace-11-2-20.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2020-11-03 01:52:212020-11-03 01:52:21PerkinElmer Expands Horizons with $383 Million CRISPR Tech Acquisition